PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells
Laura Rosa Mangiapane(University of Palermo), Giorgio Stassi(University of Palermo), Veronica Veschi(Sapienza University of Rome), Davide Stefano Sardina(University of Palermo), Alice Turdo(Department of Health), Simone Di Franco(University of Palermo), Melania Lo Iacono(University of Palermo), Annalisa Nicotra(University of Palermo), Luca Fagnocchi(University of Trento), Miriam Gaggianesi(University of Palermo), Michele Signore(Istituto Superiore di Sanità), Alessio Zippo(University of Trento), Jan Paul Medema(Amsterdam Neuroscience), Ruggero De Maria(Università Cattolica del Sacro Cuore), Paola Bianca(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Matilde Todaro(University of Chieti-Pescara), Micol Eleonora Fiori(Istituto Superiore di Sanità), Sven Beyes(University of Trento), Maria Rita Bongiorno(University of Palermo), Gaspare Gulotta(University of Palermo), Gloria Ganduscio(University of Palermo), Irene Pillitteri(University of Palermo)
Cited by 103
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Identification and expansion of the tumorigenic lung cancer stem cell population
|Cell Death and Differentiation|2007|1.7k
FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC)
|The EMBO Journal|1997|1.2k
Intra-tumor heterogeneity from a cancer stem cell perspective
|Molecular Cancer|2017|828